News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,381 Results
Type
Article (40665)
Company Profile (268)
Press Release (675445)
Multimedia
Podcasts (76)
Webinars (17)
Section
Business (204737)
Career Advice (2018)
Deals (35521)
Drug Delivery (103)
Drug Development (81397)
Employer Resources (173)
FDA (16357)
Job Trends (14939)
News (346429)
Policy (32733)
Tag
Academia (2562)
Accelerated approval (16)
Adcomms (24)
Allergies (122)
Alliances (49689)
ALS (140)
Alzheimer's disease (1581)
Antibody-drug conjugate (ADC) (243)
Approvals (16493)
Artificial intelligence (433)
Autoimmune disease (104)
Automation (31)
Bankruptcy (361)
Best Places to Work (11639)
BIOSECURE Act (20)
Biosimilars (157)
Biotechnology (175)
Bladder cancer (134)
Brain cancer (45)
Breast cancer (511)
Cancer (4066)
Cardiovascular disease (337)
Career advice (1700)
Career pathing (33)
CAR-T (236)
CDC (42)
Cell therapy (629)
Cervical cancer (32)
Clinical research (68663)
Collaboration (1379)
Company closure (4)
Compensation (971)
Complete response letters (45)
COVID-19 (2685)
CRISPR (80)
C-suite (619)
Cystic fibrosis (134)
Data (5132)
Decentralized trials (2)
Denatured (24)
Depression (103)
Diabetes (441)
Diagnostics (6565)
Digital health (38)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (197)
Drug pricing (161)
Drug shortages (28)
Duchenne muscular dystrophy (201)
Earnings (89669)
Editorial (48)
Employer branding (21)
Employer resources (151)
Events (116067)
Executive appointments (932)
FDA (18922)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (20)
Funding (1244)
Gene editing (174)
Generative AI (32)
Gene therapy (506)
GLP-1 (898)
Government (4617)
Grass and pollen (6)
Guidances (373)
Healthcare (18866)
HIV (47)
Huntington's disease (36)
IgA nephropathy (71)
Immunology and inflammation (224)
Immuno-oncology (22)
Indications (63)
Infectious disease (2916)
Inflammatory bowel disease (177)
Inflation Reduction Act (13)
Influenza (95)
Intellectual property (197)
Interviews (315)
IPO (16617)
IRA (48)
Job creations (3651)
Job search strategy (1428)
Kidney cancer (15)
Labor market (78)
Layoffs (542)
Leadership (28)
Legal (7950)
Liver cancer (87)
Longevity (12)
Lung cancer (577)
Lymphoma (294)
Machine learning (30)
Management (59)
Manufacturing (620)
MASH (149)
Medical device (13667)
Medtech (13701)
Mergers & acquisitions (19822)
Metabolic disorders (1099)
Multiple sclerosis (137)
NASH (18)
Neurodegenerative disease (220)
Neuropsychiatric disorders (60)
Neuroscience (2593)
NextGen: Class of 2025 (6520)
Non-profit (4498)
Now hiring (59)
Obesity (509)
Opinion (244)
Ovarian cancer (145)
Pain (157)
Pancreatic cancer (180)
Parkinson's disease (235)
Partnered (29)
Patents (422)
Patient recruitment (344)
Peanut (53)
People (58409)
Pharmaceutical (63)
Pharmacy benefit managers (25)
Phase I (21360)
Phase II (30201)
Phase III (22539)
Pipeline (3320)
Policy (252)
Postmarket research (2592)
Preclinical (9115)
Press Release (64)
Prostate cancer (201)
Psychedelics (42)
Radiopharmaceuticals (258)
Rare diseases (633)
Real estate (5957)
Recruiting (69)
Regulatory (23680)
Reports (51)
Research institute (2365)
Resumes & cover letters (351)
Rett syndrome (20)
RNA editing (13)
RSV (70)
Schizophrenia (130)
Series A (201)
Series B (155)
Service/supplier (11)
Sickle cell disease (78)
Special edition (20)
Spinal muscular atrophy (150)
Sponsored (36)
Startups (3608)
State (2)
Stomach cancer (15)
Supply chain (96)
Tariffs (79)
The Weekly (50)
Vaccines (918)
Venture capital (69)
Weight loss (328)
Women's health (63)
Worklife (17)
Date
Today (129)
Last 7 days (820)
Last 30 days (3532)
Last 365 days (30456)
2025 (27654)
2024 (35232)
2023 (40091)
2022 (51187)
2021 (55733)
2020 (54100)
2019 (46575)
2018 (35048)
2017 (32154)
2016 (31501)
2015 (37596)
2014 (31373)
2013 (26416)
2012 (28629)
2011 (29308)
2010 (27370)
Location
Africa (737)
Alabama (74)
Alaska (7)
Arizona (279)
Arkansas (13)
Asia (38816)
Australia (6354)
California (9933)
Canada (2959)
China (901)
Colorado (417)
Connecticut (433)
Delaware (282)
Europe (83970)
Florida (1473)
Georgia (316)
Hawaii (2)
Idaho (61)
Illinois (738)
India (51)
Indiana (471)
Iowa (18)
Japan (334)
Kansas (122)
Kentucky (35)
Louisiana (24)
Maine (70)
Maryland (1275)
Massachusetts (7193)
Michigan (292)
Minnesota (563)
Mississippi (5)
Missouri (115)
Montana (30)
Nebraska (25)
Nevada (106)
New Hampshire (73)
New Jersey (2702)
New Mexico (28)
New York (2655)
North Carolina (1314)
North Dakota (8)
Northern California (4718)
Ohio (294)
Oklahoma (20)
Oregon (37)
Pennsylvania (2064)
Puerto Rico (19)
Rhode Island (43)
South America (1101)
South Carolina (54)
South Dakota (1)
Southern California (3829)
Tennessee (155)
Texas (1523)
United States (35647)
Utah (293)
Vermont (1)
Virginia (230)
Washington D.C. (78)
Washington State (809)
West Virginia (4)
Wisconsin (84)
Wyoming (2)
716,381 Results for "boehringer ingelheim fremont inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Boehringer Ingelheim Bets up to Nearly $1B in ADC Play With AimedBio Deal
2025 has been a busy year for Boehringer Ingelheim, which has so far inked at least five hefty partnerships—including its latest one with South Korea’s AimedBio for an antibody-drug conjugate therapy for cancer.
October 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Orsini Selected as Specialty Pharmacy Partner for Boehringer Ingelheim’s JASCAYD® (nerandomilast)
October 15, 2025
·
2 min read
Press Releases
Numab Therapeutics Achieves Milestone in Collaboration with Boehringer Ingelheim
September 26, 2025
·
2 min read
Press Releases
Boehringer Ingelheim advances cancer antibody-drug conjugate portfolio with asset from AimedBio
October 16, 2025
·
4 min read
Press Releases
Boehringer Ingelheim acquires license from Kyowa Kirin aimed at developing a novel treatment for patients with autoimmune diseases
October 30, 2025
·
3 min read
Press Releases
Boehringer Ingelheim Obtains Novel Preclinical Oncology Program from Accent Therapeutics
October 9, 2025
·
2 min read
Approvals
Boehringer Ingelheim Breaks Decade-Long Approval Drought in Idiopathic Pulmonary Fibrosis
In the Phase III FIBRONEER-IPF study, Jascayd demonstrated significant lung capacity improvements over placebo.
October 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global Licensing Agreement for CDR111, an Antibody-Based Trispecific M-gager® for Autoimmune Diseases
November 5, 2025
·
3 min read
Press Releases
Boehringer Ingelheim launches new direct-to-consumer platform to expand patient access to important treatments
September 30, 2025
·
4 min read
Press Releases
Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim
September 23, 2025
·
3 min read
1 of 71,639
Next
